This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now

Amanda Haas
Business Development Manager, Gene Editing Therapeutics at Agilent Technologies
Speaker

Profile

Amanda Haas is a Business Development Manager at Agilent Technologies with over 19 years of experience in life sciences and biotechnology. She has been with Agilent for 3 years, growing gene editing therapeutic services, using market research, voice of the customer and collaborating with the development team. Amanda holds a B.S. degree in Chemistry from the University of Miamy. She previously worked at Horizon Discovery, Dharmacon, and Thermo Fisher Scientific.


Agenda Sessions

  • Advanced Manufacturing Partnerships: Innovative Solutions for Oligo Programs

    , 12:00pm
    View Session

At this event

Prev
Next
Robert Hagopian
Director Business Development
PolyPeptide Group

See Amanda at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now